Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies ...

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the WorldBASKING RIDGE, N.J. , Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ...

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal 'Vaccines'.

Novel magnetoelectric nanotherapy shrinks pancreatic tumors & extends survival in preclinical study, signaling an advance in targeted cancer treatment The Silicon Review.

Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors ...

New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

Steve Merlin works with fellow pancreatic cancer patients, telling his remarkable story of surviving 13 years since his ...

Human trials could begin as early as this month at all three Mayo Clinic locations — in Florida, Minnesota and Arizona — with patients who are newly diagnosed with glioblastoma. The first phase of the ...